News & Resources
Novartis Receives EC Approval for New Indications for Cancer Drug Rydapt - by Drug Discovery & Development (9/20/17)
Drug Breakthrough for Mosquito Virus Outbreaks - by Griffith University (8/31/17)
'Unrealistic' serialization deadline? FDA offers one year grace period - by Flora Southey (7/4/17)
'Don't Underestimate Merck's vaccine business,' says CEO - by Dan Stanton (6/7/17)
Bayer, Novartis Gain New FDA Approvals for Cancer Drugs - by Ryan Bushey (5/1/17)
Teva's Austedo is first 'heavy hydrogen' drug to win US FDA approval - by Gareth MacDonald (4/12/17)
AstraZeneca ovarian cancer drug slows disease markedly in study - by Ben Hirschler (3/14/17)
GPCRs, Desirable Therapeutic Targets in Oncology - by Lee Schalop (1/25/17)
Hematology/Oncology Pharmacy Association -
International Society for Pharmaceutical Engineering -
Sanofi Expanding Fabrazyme Plant in MA - by Dan Stanton (1/31/18)
Lack of Sterility Assurance Leads to Recall of Numerous PharMEDium lots - by FDA MedWatch (1/3/18)
Merck KGaA to Transfer Tech for Vaccine Manufacturing site in Ghana - by Flora Southey (12/19/17)
Ansell to Acquire Isolator Glove Company gammaSUPPLIES - Press Release Ansell/gS (11/27/17)
A Comprehensive Approach to USP <800> - by Gary Houchard et al. (11/21/17)
FDA Approves Roche Drug for Rare Blood Cancer - by Joanne Van Zuidam (11/07/17)
GSK Receives WHO Prequalification for Synflorix Pneumococcal Vaccine Four-Dose Vial - by GSK (10/19/17)
Biotech says its vaccines target and kill cancer cells, with fewer side effects - by Flora Southey (10/2/17)
Parenteral Drug Association -
U.S. Pharmacopeial Convention -